CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Option exercise CEO and President acquired 18,000 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 9,000 shares (option exercise)
- 4 Option exercise Chief Scientific Officer acquired 9,000 shares (option exercise)
- 4 Option exercise See Remarks acquired 9,000 shares (option exercise)
- 8-K Event Unregistered share sale
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Option exercise CEO and President acquired 383 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 68 shares (option exercise)
- 4 Option exercise See Remarks acquired 68 shares (option exercise)
Page 2 of 34 · 672 filings